How to buy IQVIA stock (IQV)

IQVIA is a diagnostics & research business based in the US. IQVIA shares (IQV) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $200.25 – an increase of 1.51% over the previous week. IQVIA employs 88,000 staff and has a trailing 12-month revenue of around $15.3 billion.

Our top picks for where to buy IQVIA stock

Buy IQVIA stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

IQVIA stock price (NYSE: IQV)

Use our graph to track the performance of IQV stocks over time.

IQVIA shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$200.25
52-week range	$187.62 - $261.73
50-day moving average more info button	$208.18
200-day moving average more info button	$227.07
Wall St. target price	$249.54
PE ratio more info button	26.2454
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$7.62

Is it a good time to buy IQVIA stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IQVIA price performance over time

Historical closes compared with the close of $199.11 from 2024-12-23

1 week (2024-12-20)	0.93%
1 month (2024-11-27)	-1.15%
3 months (2024-09-27)	-15.20%
6 months (2024-06-27)	-6.41%

1 year (2023-12-27)	-14.15%
2 years (2022-12-27)	-1.89%
3 years (2021-12-27)	282.06
5 years (2019-12-27)	28.92%

Is IQVIA stock undervalued or overvalued?

Valuing IQVIA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IQVIA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IQVIA's P/E ratio

IQVIA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, IQVIA shares trade at around 26x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

IQVIA's PEG ratio

IQVIA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0561. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IQVIA's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

IQVIA's EBITDA

IQVIA's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.

The EBITDA is a measure of a IQVIA's overall financial performance and is widely used to measure a its profitability.

IQVIA financials

Revenue TTM	$15.3 billion
Operating margin TTM	14.84%
Gross profit TTM	$5 billion
Return on assets TTM	5.11%
Return on equity TTM	22%
Profit margin	9.17%
Book value	$38.37
Market Capitalization more info button	$36.3 billion

TTM: trailing 12 months

IQVIA's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IQVIA.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

IQVIA's total ESG risk score

Total ESG risk: 26.81

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IQVIA's overall score of 26.81 (as at 12/31/2018) is pretty good – landing it in it in the 37th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like IQVIA is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

IQVIA's environmental score

Environmental score: 1.17/100

IQVIA's environmental score of 1.17 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that IQVIA is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

IQVIA's social score

Social score: 14.76/100

IQVIA's social score of 14.76 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that IQVIA is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

IQVIA's governance score

Governance score: 6.88/100

IQVIA's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that IQVIA is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

IQVIA's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. IQVIA scored a 1 out of 5 for controversy – the highest score possible, reflecting that IQVIA has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

IQVIA Holdings Inc was last rated for ESG on: 2019-01-01.

Total ESG score	26.81
Total ESG percentile	36.72
Environmental score	1.17
Environmental score percentile	3
Social score	14.76
Social score percentile	3
Governance score	6.88
Governance score percentile	3
Level of controversy	1

IQVIA share dividends

We're not expecting IQVIA to pay a dividend over the next 12 months.

IQVIA share price volatility

Over the last 12 months, IQVIA's shares have ranged in value from as little as $187.62 up to $261.73. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while IQVIA's is 1.513. This would suggest that IQVIA's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IQVIA overview

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.

Frequently asked questions

What percentage of IQVIA is owned by insiders or institutions?
Currently 0.924% of IQVIA shares are held by insiders and 94.545% by institutions. How many people work for IQVIA?
Latest data suggests 88,000 work at IQVIA. When does the fiscal year end for IQVIA?
IQVIA's fiscal year ends in December. Where is IQVIA based?
IQVIA's address is: 2400 Ellis Road, Durham, NC, United States, 27703 What is IQVIA's ISIN number?
IQVIA's international securities identification number is: US46266C1053 What is IQVIA's CUSIP number?
IQVIA's Committee on Uniform Securities Identification Procedures number is: 74876Y101